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Objectives This study sought to evaluate the ability of minimal luminal area (MLA) measured by
intravascular ultrasound (IVUS) to assess the functional signiﬁcance of coronary artery disease.
Background The use of IVUS to determine the functional signiﬁcance of coronary artery lesions re-
mains a matter for debate.
Methods From our prospective IVUS imaging database, between July 2009 and April 2010, 170 cor-
onary lesions in 150 patients who underwent stress myocardial single-photon emission computed
tomography (SPECT) performed within 1 month of IVUS evaluation were identiﬁed and analyzed.
MLA and other parameters were measured by IVUS and compared with the results of myocardial
SPECT.
Results Overall, 45 lesions had positive SPECT, and 125 lesions had negative SPECT. The MLA of
lesions with positive SPECT was smaller than the MLA of those with negative SPECT (1.7  0.5 mm2
vs. 2.3  1.1 mm2, p  0.001). By logistic regression analysis, MLA (odds ratio: 3.1 by decrease of
mm2, 95% conﬁdence interval [CI]: 1.75 to 5.5, p  0.01) was an independent predictor of the
positive SPECT. Using receiver-operator characteristic curve analysis, the best cutoff value of MLA
was 2.1 mm2 with an 86.7% sensitivity, a 50.4% speciﬁcity, a 38.6% positive predictive value, and a
1.3% negative predictive value versus lesions with a positive SPECT (area under the curve: 0.690,
5% CI: 0.615 to 0.759, p  0.01).
onclusions The best cutoff value of MLA measured by IVUS to predict myocardial ischemia was
.1 mm2. The IVUS-measured MLA appeared to play a limited role in detecting functionally signiﬁ-
ant lesions assessed by myocardial SPECT. (J Am Coll Cardiol Intv 2011;4:665–71) © 2011 by the
merican College of Cardiology Foundation
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666Current guidelines recommended noninvasive functional
study before performing elective coronary intervention (1,2).
Furthermore, a recently published, large randomized trial
demonstrated the clinical benefit of coronary stenting based on
invasive functional evaluation (3). Intravascular ultrasound
(IVUS) has provided valuable information on cross-sectional
coronary vascular structure with high spatial resolution and has
played a key role in contemporary interventional cardiology (1).
here have been attempts to determine the IVUS parameters
orresponding to the functional significance of a coronary
rtery narrowing to integrate target lesion anatomy and phys-
ology. Although several IVUS criteria have been suggested as
n equivalent to physiological assessment (4–6), this approach
emains controversial (7,8). Therefore, we sought to validate
he ability of IVUS measurements, especially minimal luminal
rea (MLA), to assess the functional significance of coronary
rtery disease in comparison with the gold standard of myo-
ardial perfusion imaging.
Methods
Study population. From our pro-
spective IVUS imaging database,
between July 2009 and April
2010, 283 major epicardial coro-
nary artery stenoses in 255 pa-
tients who underwent stress myo-
cardial single-photon emission
computed tomography (SPECT)
within 1 month of IVUS evalua-
tion were identified. Of these le-
sions, 2 or more stenoses in 1
coronary vessel (n  14), bypass
graft lesions (n  18), left main
coronary artery disease (n  41),
in-stent restenosis (n  15), le-
ions with visible collateral development (n  1), lesions
corresponding to a fixed perfusion defect (n  9), and
undetermined vascular territory (n  15) on SPECT imaging
were excluded. Finally, 170 major epicardial coronary artery
stenoses in 150 patients were included in the analysis. This
study was approved by the institutional review boards, and all
patients provided written informed consent.
Myocardial perfusion imaging. Gated thallous chloride (Tl-
201) SPECT images were acquired after adenosine stress
testing (post-stress SPECT) and again 4 h after the injec-
tion of Tl-201 chloride (redistribution SPECT). Patients
abstained from caffeine-containing foods, beverages, and
drugs such as aminophylline and theophylline 24 h before
the test. Adenosine was intravenously administered at a rate
of 140 g/kg/min for 6 min. Three minutes after the ini-
tiation of the adenosine infusion, a dose of Tl-201 (range
92.5 to 148 MBq, determined by the subject’s body weight)
Abbreviations
and Acronyms
CI  confidence interval
IVUS  intravascular
ultrasound
MLA  minimal luminal area
NPV  negative predictive
value
PPV  positive predictive
value
QCA  quantitative coronary
angiography
SPECT  single-photon
emission computed
tomography
Tl-201  thallous chloridewas injected intravenously. Six min after adenosine infusion, ppost-stress myocardial perfusion images were acquired with
a 2-head gamma camera (Ecam, Siemens, Germany)
equipped with low-energy, all-purpose collimators (64 64
matrix, 32 projections over 180°, 8 frames per cardiac cycle,
50 s per projection). A zoom factor of 1.78 was used. The
pixel size was 5.4 mm. Transaxial slices were reconstructed
with a Butterworth filter (order 5; cutoff frequency 0.35).
No attenuation or scatter correction was applied. Stress and
rest tomographic images were displayed side by side in the
short-axis, horizontal long-axis, and vertical long-axis re-
construction planes.
A 16-segment model was used in which myocardial
segments were allocated to the territories of different coro-
nary arteries as previously described (9,10). A vascular
territory was classified as showing “no perfusion defect” if all
segments in the territory had normal quantitative uptake. A
vascular territory was considered as having a “perfusion
defect” if quantitative tracer uptake in any segment within
the vascular territory on the stress image was 75%. Each
territory with a perfusion defect was further classified as
“reversible” if any of the segments with a stress defect
quantitatively improved tracer uptake at rest or “fixed” if
segments with a stress defect showed no change or a further
decrease in tracer uptake at rest. Accordingly, the result was
considered positive when a “reversible perfusion defect” or
negative when a “no perfusion defect” was allocated to the
perfusion territory of the coronary artery of interest.
IVUS examination and measurement. IVUS imaging was per-
formed after intracoronary administration of 0.2 mg nitroglycerin
to prevent vessel spasm using motorized transducer pullback (0.5
mm/s) and a commercial scanner (Boston Scientific/SCIMED,
Minneapolis, Minnesota), consisting of a rotating 40-MHz trans-
ducer within a 3.2-F imaging sheath. The decision to perform
IVUS was at the operator’s discretion. Quantitative IVUS analysis
was performed as previously described (11,12) in a core laboratory
at the Asan Medical Center using computerized planimetry
(EchoPlaque 2.7, Indec Systems, Mountain View, California).
Quantitative measurement was done at the most severe stenotic
lesion in each coronary vessel. MLA, plaque burden (external
elastic membrane minus lumen divided by external elastic mem-
brane), and external elastic membrane area and diameters were
measured at the lesion site.
Angiographic analysis. Qualitative coronary angiography
(QCA) measurements including percentage diameter steno-
sis, reference vessel diameter, and minimal luminal diameter
were done using standard techniques with automated edge-
detection algorithms (CASS-5, Pie-Medical, Maastricht,
the Netherlands) in the angiographic analysis center of the
Cardiovascular Research Foundation (Seoul, Korea) (13).
Angiographic image acquisition was performed at target
sites using 2 angiographic projections of the coronary
narrowing.
Statistics analysis. Data were analyzed on a per-patient ander-lesion basis for the corresponding calculations. Contin-
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667uous variables are presented as mean  SD and were
compared with Student t test. Categorical variables are
presented as counts or percentages. Receiver-operator char-
acteristic curve analyses were performed to assess the dis-
criminate power of the IVUS and QCA parameters using
MedCalc (MedCalc Software, Mariakerke, Belgium) to
define sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) with 95%
confidence intervals (CIs). The best cutoff values of IVUS
and QCA parameters to determine positive SPECT were
identified as the values with the highest sum of sensitivity
and specificity. Furthermore, the kappa statistic was used to
evaluate the agreement of functional significance between
Table 1. Demographic and Clinical Characteristics (n  150)
Age, yrs 62.5 9.8
Male/female 109/41
Hypertension 98 (65.3)
Hyperlipidemia 101 (67.3)
Diabetes 44 (29.3)
Smoking 33 (22.0)
Previous history of PCI 11 (7.3)
Number of diseased vessels
1 74 (43.5)
2 65 (38.2)
3 31 (18.2)
Clinical manifestation
Stable angina 133 (88.7)
Unstable angina 11 (7.3)
Acute myocardial infarction 6 (4.0)
Vessel investigated, n  170
Left anterior descending artery 111 (65.3)
Left circumﬂex artery 20 (11.8)
Right coronary artery 39 (22.9)
Values are mean SD or n (%).
PCI percutaneous coronary intervention.
Table 2. Angiographic and Intravascular Ultrasound P
All (n  170)
QCA parameters
Reference vessel diameter, mm 3.3 0.6
Minimal luminal diameter, mm 1.5 0.4
Percentage of diameter stenosis 55.3 10.7
Lesion length, mm 21.2 11.1
IVUS parameters
Minimal luminal area, mm2 2.1 1.0
Lesion vessel area, mm2 11.8 4.4
Lesion vessel diameter, mm 3.8 0.7
Plaque burden, % 79.8 10.6
Values are mean SD.IVUS intravascular ultrasound; QCA quantitative coronary angiographIVUS or QCA cutoff values and the results of myocardial
SPECT. Multivariate logistic regression analysis was also
performed to determine the independent predictors of
positive SPECT. The IVUS and QCA parameters such as
MLA, plaque burden, minimal lumen diameter, diameter
stenosis, vessel size, and lesion length were entered into the
multivariate model and backward stepping was used to
determine the independent predictors. A p value 0.05 was
considered statistically significant.
Results
The demographic and clinical characteristics of the study
population were summarized in Table 1. Patient age was
62.5  9.8 years. Approximately 30% of patients had diabetes
ellitus. Stable angina was the most frequent indication for
oronary angiogram. One-, two-, and three-vessel coronary
rtery disease was present in 43.5%, 38.2%, and 18.2% of study
atients, respectively. The left anterior descending artery was
he most frequently investigated vessel.
In total, 45 lesions had positive SPECT, and 125 lesions
ad negative SPECT. IVUS and QCA measurements are
ummarized in Table 2. Between lesions with positive versus
egative SPECT, reference vessel diameter was almost
dentical. However, MLA and minimal luminal diameter were
maller in lesions with positive SPECT. In addition, diameter
tenosis, vessel size, and plaque burden were larger. The lesion
ength tended to be longer in lesions with positive SPECT but
id not reach the statistical significance.
Using receiver-operator characteristic curve analysis, the
est cutoff value of IVUS MLA to predict positive SPECT
as 2.1 mm2, with an 86.7% sensitivity, a 50.4% speci-
ficity, a 38.6% PPV, and a 91.3% NPV in predicting the
lesions with positive SPECT (Fig. 1). The kappa value was
0.27, indicating poor agreement between myocardial
SPECT and IVUS-measured MLA at the best determined
eters
Myocardial SPECT
p Valuesitive (n  45) Negative (n  125)
3.3 0.5 3.3 0.6 0.892
1.3 0.4 1.5 0.4 0.002
60.3 10.6 53.5 10.2 0.001
23.7 11.9 20.4 10.8 0.091
1.7 0.5 2.3 1.1 0.001
12.9 4.0 11.4 4.4 0.059
4.0 0.7 3.8 0.7 0.06
85.5 6.9 77.7 11.0 0.001aram
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668cutoff value. Diagnostic performance of other IVUS and
QCA parameters to detect a functionally significant coro-
nary stenosis assessed by myocardial SPECT are summa-
rized in Table 3.
When the receiver-operator characteristic curve analysis
was repeated in 73 lesions with single-vessel disease, the
area under the curve was 0.740 (95% CI: 0.625 to 0.834,
p  0.001); and the best cutoff value was 2.1 mm2 with
sensitivity of 91.6%, specificity of 64.0%, PPV of 55.0%,
and NPV of 94.1%. By contrast, in 96 lesions with multi-
vessel disease, the area under the curve was 0.657 (95% CI:
0.554 to 0.751, p  0.014); and the best cutoff value was
1.6 mm2 with sensitivity of 66.7%, specificity of 69.3%,
PV of 37.8%, and NPV of 88.1%.
In addition, a subanalysis was performed according to
eference vessel diameter. In 121 lesions of reference vessel
iameter 3 mm, the best cutoff value of IVUS-measured
Figure 1. SPECT Versus IVUS Measured MLA in All Lesions
Scatterplot (A) and receiver-operator characteristic curve (B) of single-photon
measured minimal luminal area (MLA) in all lesions. AUC  area under the cu
Table 3. Diagnostic Performance of IVUS and QCA Parameters to Detect a
AUC* p Value BCV Sen
QCA parameters
MLD, mm 0.670 (0.594–0.740) 0.001 1.26 57.8 (4
DS, % 0.692 (0.617–0.761) 0.001 58.2 62.2 (4
LL, mm 0.582 (0.504–0.658) 0.12 26.2 43.2 (2
IVUS parameters
MLA, mm2 0.690 (0.615–0.759) 0.001 2.1 86.7 (7
PB, % 0.730 (0.656–0.795) 0.001 83.4 73.3 (5
*95% confidence interval.
AUC  area under the curve; BCV  best cutoff value; DS  diameter stenosis; LL  lesion lenPB plaque burden; PPV positive predictive value; SPECT single-photon emission computed tomogrLA was 2.1 mm2. However, in 49 lesions of reference
vessel diameter 3 mm, IVUS-measured MLA lost its dis-
riminatory power to predict an abnormal myocardial SPECT
area under the curve: 0.586, p 0.942). A further subanalysis
is summarized in Table 4.
By multivariate logistic regression analysis, the indepen-
dent determinant of positive SPECT among the IVUS and
QCA parameters was an IVUS-measured MLA (odds ratio:
3.1 by decrease of 1 mm2, 95% CI: 1.75 to 5.5, p  0.01).
Discussion
Decisions regarding coronary intervention should be based
on objective evidence of functional significance of coronary
artery narrowing. Even in the drug-eluting stent era, every
coronary intervention carries the risk of procedural-associated
complications, late stent thrombosis, and restenosis (14). Fur-
on computed tomography (SPECT) versus intravascular ultrasound (IVUS)-
 conﬁdence interval.
tionally Significant Stenosis Evaluated by Myocardial SPECT
Specificity PPV NPV Kappa
.3) 76.8 (68.4, 83.9) 47.3 (33.5, 61.3) 83.5 (75.4, 89.7) 0.32
.2) 70.4 (61.6, 78.2) 43.1 (30.8, 56.0) 83.8 (75.3, 90.3) 0.28
.0) 79.2 (71.0, 85.9) 42.2 (27.5, 58.0) 79.8 (71.7, 86.5) 0.21
.9) 50.4 (41.3, 59.5) 38.6 (29.1, 48.8) 91.3 (81.9, 96.8) 0.27
.4) 64.8 (55.8, 73.1) 42.9 (31.6, 54.7) 87.1 (78.5, 93.2) 0.31
LA  minimal luminal area; MLD  minimal luminal diameter; NPV  negative predictive value;emissiFunc
sitivity
2.2, 72
6.5, 76
8.3, 59
3.2, 94
8.1, 85
gth; Maphy; other abbreviations as in Table 2.
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669thermore, noninvasive or invasive functional studies triage
patients who benefit most from coronary intervention (15,16).
Therefore, current guidelines highlight the functional evalua-
tion of a target coronary lesion before elective intervention (2).
owever, noninvasive functional study is not always performed
efore coronary intervention (17). In addition, an intraproce-
ural invasive functional study increases time and cost. There-
ore, to identify the functional threshold of IVUS measure-
ents that predict ischemia would be of value, especially in
atients undergoing IVUS-guided stent implantation.
The current study comparing IVUS-measured MLA
ith the results of myocardial SPECT showed that the best
utoff value was an MLA 2.1 mm2 to discriminate
functionally significant coronary artery disease. Several pre-
vious studies demonstrated a correlation between anatomic
data obtained from IVUS and functional severity assessed by
myocardial perfusion SPECT, coronary flow reserve, and
fractional flow reserve (4–6,18). Most of these reports
suggested that the optimal threshold of MLA was 4 mm2
to detect a functionally significant coronary artery narrow-
ing. However, MLA of 4 mm2 theoretically yields 50%
diameter stenosis in the usually treated coronary vessel with
diameters ranged between 2 and 4 mm. Therefore, it might
not have a critical effect on blood flow (7,19). In addition,
previous studies enrolled coronary lesions with relatively
mild stenoses and larger vessel diameters that likely in-
creased the MLA cutoff value to 4.0 mm2. In the current
tudy, evaluated lesions were enrolled from a “real-world”
rospective IVUS cohort and, therefore, had a smaller
LA cutoff than other previous studies (4–6,18).
The PPV of the current IVUS MLA criteria was too low
or clinical decision making. In addition, the agreement of
he result between IVUS MLA criteria and myocardial
PECT was poor, considering the kappa statistic of 0.27. A
Table 4. Diagnostic Performance of IVUS Measured MLA to Detect a Func
Important Subgroups
AUC* p Value BCV S
RVD
3 mm (n  121) 0.729 (0.641–0.806) 0.001 2.1 87
3 mm (n  49) 0.586 (0.436–0.724) 0.942 2.0 83
Lesion length
26.2 mm (n  45) 0.683 (0.528–0.814) 0.025 1.96 84
26.2 mm (n  125) 0.676 (0.586–0.757) 0.001 2.0 80
Vascular extent
SVD (n  74) 0.740 (0.625–0.835) 0.001 2.1 91
MVD (n  96) 0.657 (0.554–0.751) 0.014 1.6 66
Lesion location
LAD (n  111) 0.703 (0.608–0.786) 0.001 2.1 90
Non-LAD (n  59) 0.669 (0.534–0.786) 0.040 1.5 64
*95% confidence interval.
LAD left anterior descending coronary artery; MVDmultivessel disease; RVD relative vessow PPV was also consistently observed in the othernatomical QCA or IVUS parameters that were measured
n the current study. Although IVUS MLA is an important
actor to determine the coronary blood flow, other anatom-
cal factors measured by QCA or IVUS also act as the
esistance to the flow. Therefore, a single parameter such as
VUS MLA may have limitations for predicting the result
f myocardial SPECT.
In coronary vessels of reference vessel diameter3 mm in
he current study, IVUS-measured MLA lost its predictive
ower to discriminate the results of myocardial SPECT.
his finding was consistent with a previous report compar-
ng IVUS MLA and fractional flow reserve in vessels with a
iameter of 2.8 mm (20).
In the current study, the IVUS MLA cutoff value had a
90% NPV. Therefore, IVUS criteria may be useful in the
eferral of coronary intervention because it showed a high
PV for functional significance. A previous study evaluated
00 patients with 357 de novo intermediate native coronary
esions and confirmed the clinical usefulness of IVUS when
ntervention was deferred based on MLA 4 mm2, with
event rate of 4.4% and target lesion revascularization rate of
2.8% during a mean follow-up of 13 months (21). A similar
strategy to defer treatment according to the MLA was also
reported in the setting of left main coronary artery disease
with favorable clinical outcomes (22).
Theoretically, the lesion length of coronary stenosis is
another important physiological factor to determine the
resistance to the coronary blood flow (18,23). However, in
the current study, the influence of lesion length on the result
of myocardial SPECT was less obvious. In addition, sepa-
rate analysis for the IVUS-measured MLA according the
lesion length cutoff value of 26.2 mm found no significant
change of best cutoff value for the IVUS-measured MLA.
Relatively longer lesion distribution of the current study
ly Significant Stenosis Evaluated by Myocardial SPECT According to the
vity Specificity PPV NPV Kappa
, 96.6) 56.8 (45.8, 67.3) 43.3 (31.1, 56.1) 92.6 (82.1, 97.9) 0.338
, 97.9) 40.5 (24.8, 57.9) 31.2 (16.1, 50.0) 88.2 (62.6, 96.6) 0.153
, 96.6) 50.0 (29.9, 70.1) 55.2 (35.3, 73.9) 81.2 (53.3, 96.2) 0.319
, 93.4) 57.6 (47.2, 67.5) 33.3 (21.9, 46.5) 91.9 (82.1, 97.4) 0.251
, 99.0) 64.0 (49.2, 77.1) 55.0 (38.5, 70.7) 94.1 (80.3, 99.3) 0.474
, 85.4) 69.3 (57.6, 79.5) 37.8 (22.3, 55.5) 88.1 (77.1, 95.1) 0.283
, 98.0) 52.5 (41.0, 63.8) 42.4 (30.2, 55.3) 93.3 (81.7, 98.6) 0.318
, 87.2) 73.3 (58.1, 85.4) 42.9 (21.8, 66.0) 86.8 (71.9, 95.6) 0.321
ter; SVD single vessel disease; other abbreviations as in Tables 2 and 3.tional
ensiti
.8 (71.8
.3 (51.6
.2 (60.4
.8 (60.6
.7 (73.0
.7 (43.0
.3 (74.2
.3 (35.1may attenuate the impact of lesion length. In addition,
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670considering the diffuse nature of human coronary athero-
sclerosis (24), QCA lesion length could not reflect the true
physiological or anatomic lesion length. This might be
another contributing factor for the lack of lesion length
impact on myocardial perfusion.
Study limitations. First, myocardial SPECT served as a gold
standard, but it also has its own limitations to detect
functional significance of coronary artery disease, particu-
larly in the setting of multivessel disease (25). Indeed, the
number of patients with multivessel disease accounted for
56% of the current study population. However, inclusion
and exclusion of the lesions in the setting of multivessel
disease had no impact on the overall cutoff value of IVUS
MLA. By contrast, IVUS MLA cutoff value in the setting
of multivessel disease decreased, which might be partly
because of the lower sensitivity of myocardial SPECT to
detect significant coronary stenosis in the presence of
multivessel diseases. Second, although all the myocardial
SPECT were analyzed by an independent, experienced
nuclear physician, the region allocation between IVUS and
myocardial SPECT was performed under the information
of actual coronary distribution gathered by coronary
angiography. As outlined previously, the lesions with
undetermined territory were excluded in analysis. Third,
to reduce the confounding in assessment of the relation-
ship between IVUS-measured lesion anatomy and the
result of myocardial SPECT, in-stent restenosis lesions,
multiple stenotic lesions, and lesions with collateral
vessels or fixed perfusion defect on myocardial SPECT
were excluded. Fourth, the current cohort accounted for
just 15% of IVUS-evaluated lesions during the study
period. Finally, as all patients enrolled in the analysis
were Asians, small body and vessel size may cause smaller
MLA cutoff values than other previous studies in West-
ern populations.
Conclusions
In the current study, we suggested a measured lesion
MLA of 2.1 mm2 as a practical IVUS criteria corre-
ponding to functionally significant coronary artery dis-
ase. However, the low PPV limits its role in clinical
ecision making. Therefore, complementary functional
tudies are necessary for the accurate evaluation of
unctional significance of target lesions in real-world
ractice settings before or during coronary intervention.
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